ROBERT J HUGIN
CIK 1232505 · see remarks · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.35M
Companies
8
Total Filings
117
Lifetime Open-Market Net
-$160.24M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CB | Director | 21,851 | $338.74 | $7.40M | $0 | 7 | 2026-05-26 |
| BHVN | Director | 12,959 | $15.74 | $204.0K | $0 | 10 | 2025-05-07 |
| Allergan plc (AGN) Delisted | Director | 0 | — | — | $0 | 4 | 2020-05-11 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 163,431 | — | — | $0 | 16 | 2017-11-13 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 1,069,706 | — | — | -$70.81M | 50 | 2017-10-31 |
| DHR | Director | 3,576 | $206.93 | $740.0K | $0 | 3 | 2017-05-17 |
| CELGENE CORP /DE/ (CELG) Delisted | Chief Executive Officer | 1,470,028 | — | — | -$89.43M | 24 | 2010-10-14 |
| Coley Pharmaceutical Group, Inc. (COLY) Delisted | Director | — | — | — | $0 | 1 | 2007-06-15 |
Recent Filings · Page 8 of 12
117 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-12-19 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +7,351 | -$508.1K | EDGAR |
| 2012-11-02 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-08-01 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-05-24 | MEDICINES CO /DE (MDCO) Delisted | Grant (A) | +5,086 | $0 | EDGAR |
| 2012-05-01 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-17 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +8,942 | -$605.0K | EDGAR |
| 2012-02-01 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-28 | CELGENE CORP /DE/ (CELGZ) Delisted | Mixed | +35,432 | -$1.85M | EDGAR |
| 2011-11-01 | CELGENE CORP /DE/ (CELGZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-08-08 | CELGENE CORP /DE/ (CELGZ) Delisted | Buy (P) | +10,000 | $527.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.